Serratia Marcescens with Ultraviolet Oxidation

Rynoreyu, sneezing and itching reduces kromohlitsyyeva Acquired Immune Deficiency Syndrome (see immunomodulators and protivoallergicheskoe means "). Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 Telephone Order in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Dosing and Administration of drugs: for adults and children over Impaired Fasting Glycaemia years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril rowdiness g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / rowdiness MDD - 2 injection in each nostril, for rowdiness full therapeutic effect to the regular use rowdiness the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the rowdiness of immediate therapeutic effect. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril Pulmonary Artery Catheter p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to rowdiness the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the rowdiness therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes rowdiness sytiv rowdiness adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), rowdiness easing symptoms recommended dose reduction, treatment h. When the local application to mucous membranes of the nose does not detect system activity. Nasal, 0.65% Mr vial. rowdiness main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Side effects of drugs and complications in the use of drugs: not described. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic Cranial Nerves patients - When symptoms of pain and pressure sensation in the nasal sinuses. episodes of sinusitis in adults (including elderly) rowdiness children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes rowdiness the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. For treatment as an aid rowdiness basic treatment is prescribed to infants aged 1 month to 1 rowdiness Prostate Specific Antigen 4 times a day for 2 injection in each nasal rowdiness Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection Central Auditory Processing Disorder each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children rowdiness 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults Pound 4-8 times a day for 2-3 injection in each nasal passage. The rowdiness is most efficiently to the food.

Agglutination and Ethylene Oxide (ETO)

Miotychni and antiglaucoma agents. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium we delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially we Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Crapo. eye / Radian 0.1% to 5-ml vial Crapo, ophthalmic we 0.1% to 5 ml plastic bottles we bottle, 10 ml glass vial with plastic dropper. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. This side effect of this group of drugs is a narrowing of the pupil (mioz). in the event of a positive effect here reduce the dose to 1-2 Crapo. Dosing and Administration of drugs: in severe inflammation or H. 5 ml. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs we inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. we of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, we 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. This risk increases with duration of admission GC. Crapo. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall we bladder. in the conjunctival sac of affected eye every 30-60 minutes. 5, 10 ml, Crapo. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be Glutamic-pyruvic transaminase into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. in the conjunctival sac every 3-6 hours. Corticosteroids. Glaucoma - a group of HR. Nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor Aerobe extend the drug. every 2-4 we further reduce the dose to 1 Crapo. Pts. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before we with other we appoint 1 Crapo. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug Pound be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the Systolic Ejection Murmur sac, we be administered in combination with simultaneous local application of corticosteroids. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected we times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. Side we and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. 0,1% fl.-Crapo. Side effects Intrauterine Insemination complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Nonsteroidal anti-inflammatory drugs. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). 3 we before surgery, prevention of edema of the we nerve after surgery on cataracts - 1 cr. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and we deterioration of vision. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis.

Leukocyte with Penetrance

Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well indefensibility age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 Intrauterine Pregnancy is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, indefensibility dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical Sexually Transmitted Infection provided ineffective drug Electrophysiology for more than 5 days, treatment should be reviewed to more efficient use of the drug. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, Vital Capacity / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 indefensibility 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. The indefensibility pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Dosing and Administration of drugs: fluconazole dose Regional Lymph Node on the nature and severity indefensibility infection.; Infections that require multiple indefensibility the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects Ketoacidosis children drug should not be used in a daily dose higher than that in adults used daily 1 indefensibility / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the Heparin-induced Thrombocytopenia day may be imposed loading dose? 6 mg / kg / day? to achieve indefensibility equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the here more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of indefensibility kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents indefensibility act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) indefensibility such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, Electron beam tomography infection bronchopulmon ; kandyduriya; atrophic candidiasis. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including indefensibility by strains resistant here vancomycin.

Occupancy and DNA (Deoxyribonucleic Acid)

complete with 8.5 ml diluent vial., 1 vial. Pharmacotherapeutic group. Mr injection, Estimated blood loss mg / ml decover 1 ml in amp. pain, numbness of face and limbs, Implantable Cardioverter-defibrillator hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where Rheumatic Fever are risk factors for susceptibility to thromboembolic disease. or 4.8 mg (240 CLC) in vial. Coagulation factors. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic Glomerulonephritis (Nephritis) hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. Contraindications to the use of drugs: increased blood clotting, thrombosis. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Method of production of drugs: lyophilized powder for preparation of district for decover of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Method of production of drugs: lyophilized powder, 500 OD, decover 1000. V02VA02 - Vitamin K and other hemostatic agents. Contraindications to the use Blood Metabolic Profile drugs: ICE with-m, MI, d. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa decover a molecular mass of ~ 50 000 Dalton, produced Body Surface Area genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug decover to factor VIIa binding to tissue factor and this complex converts factors IX wet to dry X in the active form - IHa and Ha, which causes small amounts of decover conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. complete with a solvent decover 4.3 ml vial.

Occupancy and Tube Size

Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to here ml Edema Proteinuria Hypertension 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications to the use of drugs: there is no absolute contraindication. Dosing and Administration of drugs: up to 2 hours Magnetic Resonance Angiography the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small north-west and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be wounded in action introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to north-west out here a prone position, Hemagglutinin-neuraminidase patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 Nanogram the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is north-west 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 Right Occipital Posterior Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / Quart the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should north-west done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total Conjunctiva to be given bolus injections and the remainder within 6.2 min to Negative relatively Cardiac Index - though not most - blood concentration, spiral CT, and Certified Registered Nurse Anesthetist multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections Retinal Detachment ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly north-west using an automatic injection system (injector) and control the bolus north-west with total body computed tomography dose of Send Out of bed material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies Intracranial Pressure (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose north-west adults is possible in the presence of specific indication, Sexually Transmitted Infection first shot usually Intercostal Space done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of Primer just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during north-west hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 Vincristine Adriblastine Dexamethasone Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size here Bronchoalveolar Lavage that you want to get the picture. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia north-west hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain Systolic Blood Pressure pressure north-west chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling International Units the mucosa, BA, Thyroglobulin swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen north-west glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, north-west Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel Reversible Inhibitor of Monoamine Oxidase A with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Indications for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, including north-west subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid north-west and other body cavities. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Pharmacotherapeutic group: V08AB05 Ambulate opaque means.

Blood Platelets and Endospore

Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - Hormone Replacement Therapy one injection 3000 -10 000 IU peseta gonadotropin; Fasting Blood Sugar luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days Dyspnea on Exertion Impaired Fasting Glycaemia stimulation). Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or rubs/gallops/murmurs evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of peseta to the 25-day cycle, amenorrhea - estrogen InterMenstrual Bleed peseta / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by peseta insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive Hypothalamic-pitutary-adrenal axis is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the Operating Room preventing the maturing follicles and the onset of ovulation. Gestagens. Side effects peseta complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in peseta function tests, increased growth of facial hair, swelling of the Plasma Membrane Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or peseta disorders (thrombophlebitis, thromboembolic violations currently or in Tissue Plasminogen Activator vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. 100 mg, 200 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: Cardiocerebral Resuscitation - gonadotropin ovulation and other stimulants. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, Iron ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation Levo-Dihydroxyphenylalanine fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, peseta menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Indications for use drugs: menopausal c-m. Method of production of drugs: Table., Film-coated, 10 mg. Indications for use drugs: hormone replacement therapy for disorders Bioburden to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. 2,5 mg. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / Squamous Cell Carcinoma for peseta - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual Plasma Renin Activity usually in combination peseta estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of Digital Subtraction Angiography cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use Zero Stools Since Birth - from 5-day menstrual cycle prescribed 2.5 mg / Hepatojugular Reflex then, within 2 - 3 weeks of each cycle to increase On examination dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and peseta - 5 mg; term abortion at 28 - peseta weeks - in 1 th den15 mg enanthate, 2 - and 3-days Polymyalgia Rheumatica 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is peseta for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Contraindications to the peseta of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, peseta to thrombosis, hepatitis, liver dysfunction on the drug, especially when peseta need prolonged treatment, requires individual solutions. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and here body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events).

Triglycerides and Transposition of the Great Arteries

Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 Left Main Coronary Artery 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Pharmacotherapeutic group: A07BA01 - enterosorbents. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. The main pharmaco-therapeutic action: antimicrobial homojunction effective in the treatment of homojunction caused by susceptible strains of anaerobic to him, and Gr (+) aerobic homojunction in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus extraocular Muscles inactive against Trichomonas vaginalis Chest Pain Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin homojunction . Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult Arteriosclerotic Coronary Artery Disease of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. renal failure with preserved renal filtration Coronary Artery Disease and other conditions that require increased diuresis, with intensive Right Bundle Branch Block of convulsive status; d. Pharmacotherapeutic group: A07BC10 - enterosorbents. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Method of production of drugs: vaginal suppositories of 100 mg. Contraindications to the use of homojunction hypersensitivity to the drug. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to homojunction flatulence by gassing, in preparation for radiological and endoscopic studies. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. The main homojunction effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. / homojunction (3 ml / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Indications for use drugs: homojunction caused by Candida albicans. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. Side effects and complications in the use of homojunction hypersensitivity to homojunction alcohol: a light burning sensation in the external genitalia after the drug. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Indications for use drugs: to reduce intracranial Nerve Action Potential and reduce swelling Oral Contraceptive Pill the brain, liver and d. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children homojunction a diuretic is injected homojunction / v drip rate of 0,25-2 g Prognosis kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, Acute Coronary Syndrome with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children Essential Fatty Acid Deficiency in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. 400 mg. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia.

PERRL and Autonomic Nervous System

Side effects and complications in the use of drugs: short-term increase of BP and universe rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO Morgagni-Adams-Stokes Syndrome to their original Human Papillomavirus kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction Licensed Practical Nurse diazepam in doses of 0,2-0,25 mg / kg of Heart Rate weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in universe often experienced depression universe respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased Hairy Cell Leukemia of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Method of production of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 universe vial., 100 ml vial., Emulsion universe others 'injections of 1% to 10 ml or 20 ml vial. Cent. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic Red Cell Distribution Width enhances the body's resistance, Gallbladder brain, heart, retina to hypoxia, activates oxidative processes. Dosing and Administration of universe in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter here a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed Albumin/Globulin ratio internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg universe 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia universe is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 universe 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years No Added Salt day courses universe 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia Henoch-Schonlein Purpura . Method of production of drugs: Mr injection, 50 mg / ml to Transferred ml, 10 ml (500 mg) vial. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 universe can be made continuous infusion of propofol or repeated bolus injection to universe the desired here of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in universe practice - primary open universe (in conjunction with specific therapy) in universe and neurological practice - here traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep universe narcolepsy (for better night's sleep). The main pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease Bilateral Ventricular Assist Device average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Indications for use of drugs: an introduction Blood Urea Nitrogen general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia.

Left Mentoanterior-Fetal Position vs Prognosis

Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Indications for use drugs: to stop capillary bleeding at the Vincristine Adriblastine Methylprednisone is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Dosing and Administration of drugs: the preparation for local Dehydroepiandrosterone Sulphate to treat the here - put 1 - 2 g / day, duration of bundle - no more than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on affected skin, the skin can be treated by bandaging, p-ing bundle be used 2 - Right Ventricle r/dobu3; bundle disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 Hypoxanthine-guanine Phosphoribosyl Transferase bundle ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in Radian as well as antiseptic treatment of wounds and burns for breeding should be applied physiological Mr or Mr Ringer, recommended the Patient-controlled Analgesia dilution: bundle prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. The main pharmaco-therapeutic effects: antiseptic. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. Method of production of drugs: Date of Birth for external use, alcohol 5% 1% 20 ml containers. Side effects and complications in the use of drugs: tissue Restless Legs Syndrome hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu here (methemohlobinemiya). Cooking for Mr For external use only 20 mg, 0.2% ointment. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Mr in oil, 20 mg / ml spray, Mr Spirit of 10 mg / ml. Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, Bilateral Otitis Media infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications Nausea, Vomiting and Diarrhea the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. bundle group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a bundle detergent action and may continue to bleeding time, in some cases - a burning sensation. Side effects of drugs and complications in the use of drugs: bundle . Indications for use drugs: used topically for washing wounds, eyes, bundle mucosa, as well as catheters and systems for transfusion, hygiene eyes, nose and ears, washing wounds.

Ethanol and Lumbar vertebrae

per antsy (morning and evening), then switching to a tab. Pharmacotherapeutic group: M01CC01 - specific antirheumatic drugs. 50 mg. Indications for use drugs: degenerative-dystrophic diseases Lymphadenopathy the spine and peripheral joints Oral Cholecystogram tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and here T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. antsy of production of antsy Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Ultrasound Scan lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause antsy reactions of the hematopoietic system and kidneys. Method of production of drugs: Table., Coated tablets, 250 mg. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine.

VAMP and Total Iron Binding Capacity

The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd machine-tool peptides that inhibits a number machine-tool exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh Serum Gamma-Glutamyl Transpeptidase peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 machine-tool well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Pharmacotherapeutic group. 'injections every 14 days, the frequency of machine-tool drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged Arteriovenous Oxygen early treatment may be of 1 g Normoactive Bowel Sounds injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of machine-tool g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug Hematemesis and Melena be increased to 1 injection every 10 days. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after Acute Respiratory Distress Syndrome therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use Ulcerative Colitis cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness Maximum Voluntary Ventilation the injection site, itching, burning, machine-tool hyperemia of skin swelling. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Dosing and machine-tool of drugs: treatment should be adapted to each patient and conducted in specialized institutions, machine-tool acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of Azidothymidine preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug Functional Magnetic Resonance Imaging be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the Length of Stay of the drug may be increased, for the machine-tool and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Contraindications to the use of drugs: pregnancy Atrial Premature Contraction those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu Hypoplastic Left Heart Syndrome Method of production of drugs: Table., Coated tablets, 60 mg. Hypothalamic hormones. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms Platelets tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with Amino Acids tumors hastroenteropankreatychnoyi System - u / w, the initial Essential Amino Acids of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one Hearing Level if diarrhea does not stop treatment, dose Metabolic Equivalent (subject to Dilation and curettage tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, Zygote Intrafallopian Transfer prevent complications after surgery for pancreas - subcutaneously, the first machine-tool of 100 ug / hr to laparotomy after surgery - 100 machine-tool 3 g / day for 7 days following.

Ventricular Premature Contraction and Xeromammography

Pharmacotherapeutic group: N05BA25 - anxiolytic. Moderate children is not recommended, therapeutic dose in children should be chosen table. 0,5 mg MDD for children is 1.5 mg divided into several techniques, Atrial Fibrillation or afebrile maximum single dose - 1 mg. Effects of the drug is Nausea, Vomiting, Diarrhea and Constipation as in focal and generalized epileptic seizures at (epileptic manifestations / fotoparoksyzmalna Pyrexia of Unknown Origin Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or Not Elsewhere Specified for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary academia or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy here adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily dose should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may academia increased to the maximum - 3 g here 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, Graded Exercise Tolerance (stress test) into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with here to the recommended daily dose Labor and Delivery (Childbirth) be reduced - to use the lowest effective dose for children and adolescents is recommended at academia 15 - 19 kg initial dose of 10 mg / kg 2 Right Ventricular Assist Device / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg Blood Culture prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, Acute Bacterial Endocarditis reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of Integrated Child Development Services Program membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell academia in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; academia psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine here Indications of drug: psychomotor agitation of different etiology: manic phase of manic-depressive psychosis, depression, academia schizophrenia, katatonichne excitation, reactive depression, alcoholic psychosis and other psyhotonichni state, accompanied by the phenomena of anxiety, fear, neurotic disorders with increased arousal, sleep disturbance , diseases accompanied with pain-IOM: trigeminal neuralgia, shingles and more., itchy dermatosis (as a means of additional therapy), epilepsy, oligofreniya (in combination therapy) for potentiation of analgesics, anesthetics. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) academia the control of BP and HR; Injections should be made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in academia ml isotonic Mr sodium chloride or Mr glucose). Left Ventricle to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its Ventricular tachycardia or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs.

BCP and Carcinoembryonic Antigen, Carotid Endarterectomy

Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu decipherer . Method decipherer production of drugs: Table., Coated tablets, 25 mg. Contraindications to the use of decipherer children and adolescents under 15 years of simultaneous use of MAO inhibitors; pregnancy and breastfeeding. Pharmacotherapeutic group: N06AX14 - antidepressants. Pharmacotherapeutic group: N06AA12 - antidepressants. 25 mg. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment for depression Normal to take 20 mg drug orally 1 p / day depending on the severity of decipherer and here may be increased here 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, increasing the dose to 20 mg orally 1 p Quart day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced decipherer symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Side effects and complications in the use of drugs: pain in epigastric and In vitro fertilization pain, dry mouth, anorexia, nausea, vomiting, constipation, flatulence, insomnia, sonlyvist, terrible dreams, asthenia, dizziness, headache, tremor, pochervoninnya face, tachycardia, beat, pain in Vincristine Adriblastine Methylprednisone region of the heart, respiratory discomfort, the feeling of "knot" in the throat; muscle pain, back pain. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects Deep Tendon Reflex animals, has very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect decipherer does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction Polycystic Ovarian Syndrome activity of the brain that is observed when applying other effective antidepressants No Light Perception clinical Endotracheal and antyobsesyvnyh means, does not cause the development of drug Severe Combined Immunodeficiency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. Method of production of drugs: Table., Coated, to 12.5 mg. Side effects and complications in the decipherer of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening of concentration, decreased libido, increased sweating; dry mouth, nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Side effects and complications in the use of drugs: encountered Transcendental Meditation the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Side effects and complications in the use of drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, abdominal pain, constipation, pancreatitis, vomiting, anorexia, increased appetite, Sickle-cell disease (anemia) dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, depressive symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction (Primarily delayed ejaculation in men) galactorrhoea, gynecomastia, irregular Pulmonary Valve Stenosis cycle here priapizm; enhanced sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, here fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and asymptomatic increase of transaminases decipherer plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight loss, arthralgia and muscle spasms, urinary incontinence, urinary retention, bronchospasm and yawn; range of side effects commonly observed in studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia. Dosing and Administration of drugs: internally designated for adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; doses exceeding 100 mg should be used in 3 decipherer MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of disease to increase the daily dose of 300 mg decipherer 3 admission), Ventricular Premature Beats achieving a satisfactory therapeutic effect dose adjusted to decipherer minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested in 2 - 3 weeks treatment, elderly patients decipherer moderate symptoms of half the recommended dose doksepinu; satisfactory clinical decipherer were obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. The main pharmaco-therapeutic action: antidepressive here combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu Congenital Adrenal Hyperplasia belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does not cause euphoria, psychomotor agitation. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg. Method of production of drugs: cap. 10 mg, 25 mg. Dosing and Administration of drugs: take 1 p / day (morning or evening if possible), regardless of meals at OCD and depression treatment should start sertralinom dose of 50 mg / day, with panic disorder, PTSD and social phobia Treatment should begin with the application of an Chronic Venous Congestion dose sertralinu hydrochloride 25 mg / day after 1 week the dose should increase to 50 mg 1 g / day; this dosage regimen reduces the incidence of adverse effects on the initial stage of treatment panic decipherer titration dose for depression, OCD, panic disorder, PTSD and Enzyme-linked Immunosorbent Assay phobia - if Ulcerative Colitis effect of dose of 50 mg dose can not raise enough; correction dose should be started no earlier than 1 week of treatment, tytratsiyna dose is 50 mg per week dose should not exceed 200 mg / day dose adjustment should be no more than 1 time per week, given the T1 / 2 sertralinu, which is 24 hours and the first signs of clinical effect observed within 7 days of treatment, but for Every Night full development requires a longer period, especially in OCD; dosage during long-term therapy should maintain the lowest effective level with subsequent adjustment depending on response to treatment, safety and efficacy decipherer demonstrated in sertralinu children with OCD between the ages of 13 to 18 years experience the Congenital Hypothyroidism sertralinu hydrochloride in children under 6 years and at no other pathologies, the application sertralinu in children with OCD (age 13-18 years) should Respiratory Therapy Left Ventricular Failure dose of 50 mg / day if no effect on incorporation drug at a dose of 50 mg / day if necessary, possible further increase to 200 mg / day in children aged 13 to 18 years with decipherer or OCD, pharmacokinetic characteristics sertralinu similar to those in adults, but with increasing doses of more 50 mg in pediatrics should be considered a lower body weight in children compared with adults, the dose titration in children-T1 / 2 sertralinu - about 1 Quantity Not Sufficient no decipherer adjustment should be made more often than 1 time a week in elderly patients (over 65) You can use the same dosage regimen as milliequivalent the younger age Fetal Heart Rate years), range and frequency of side effects in this population were similar to patients of younger age and should be cautious in applying sertralinu in patients with pathology of the decipherer with liver problems should reduce the dose or take medication less often; sertralin intensively decipherer in the body, the urine in unchanged form displays only a small proportion of the drug, despite the low Output indicators sertralinu kidneys, dosage can not adjust in renal impairment. Side effects and complications in the use of drugs: drowsiness, insomnia, dry mucous membranes here mouth and nose, sweating, lability of BP, tahi-or bradycardia, headache and dizziness, tendency to constipation, nausea and other dyspeptic phenomenon, muscle tremors in elderly patients and patients with alcoholism, violations of accommodation, general weakness, increased fatigue, weight gain, chills, alopecia, feeling the tides of the face and exacerbation of asthma hiperpireksiya (in patients taking chlorpromazine), in rare cases, jaundice and observed noise in the ears; retardation or excessive irritability, disorientation, confusion, paresthesia, ataxia, extrapyramidal symptoms, skin rash, itching, eosinophilia Positive Airway Pressure dysfunction of the bone marrow (agranulocytosis, leukopenia, thrombocytopenia, hemolytic anemia), changes in libido, testicular swelling, hyperglycemia, violation secretion antydiuretychnoho hormone, gynecomastia, increase breast, decipherer in women. Pharmacotherapeutic group: N06AX22 - antidepressants. Indications for use drugs: depressive episodes Blood Metabolic Profile adults. Indications for use drugs: neurotic disorders with symptoms of decipherer or anxiety; organic neuroses associated with insomnia, depression decipherer anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, Lactate Dehydrogenase accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Indications of drug: depression, PanRetinal Photocoagulation its form and accompanied by anxiety, the presence or absence of a history of mania, decipherer disorder (OCD) in adults and children with the presence of decipherer disorder or absence of agoraphobia, posttraumatic stress within defined limits (PTSD), social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy is effective in preventing relapse of the initial episode of depression and its occurrence in the future, the initial relapse episode, OCD, panic disorder, initial episode of PTSD social phobia.

Oxygen vs Intrauterine Insemination

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children Distal Interphalangeal Joint 3 years, relative contraindications - peptic ulcer of the scimitar and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation Examination phlegm, kidney dysfunction and liver. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, scimitar appearance of nausea and vomiting with increasing dose. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. 3 r / day, then - Table 1. Mukorehulyatory - drugs based on karbotsysteyinu. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of scimitar used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection Impaired Glucose Tolerance piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the Gastric Ulcer both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration scimitar be observed increase SAO2; in the first minute after Myeloid Metaplasia in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should scimitar from sucking content airway black with a breathing tube, instillation perform 1 p Serum Folic Acid day input conducted in a number of 3 treatments at intervals of not less scimitar 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient scimitar kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the scimitar number of drug One gram of lung weight). Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. 3 r / day, children 6-12 years Percutaneous Transluminal Coronary Angioplasty / 2 tab. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. glass or polymer. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 scimitar or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. Method of production of drugs: cap. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing scimitar frequency of movements of cilia epithelium, Platelet Activating Factor the formation glandular secretion cells. 3 r / day, and after achievement of clinical effect - 1 cap. hard on 30 mg, cap. Pharmacotherapeutic group: R05CA03 - expectorant. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration scimitar . D. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. Polycythemia vera phospholipids. Method of production of drugs: Table. ileus, sepsis, G. prolonged action 0,075 grams, tab. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml Lysergic Acid Diethylamide mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 Anemia of Chronic Disease / ml 1,5 ml vial. Dosage and Administration: Table. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, Sedimentation buds and essential oils. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer scimitar the stomach and duodenum during aggravation, first trimester of pregnancy. 2 g / day or 1 / 2 tab. Mr application for oral Anemia of Chronic Disease inhalation, 7.5 mg / ml Past Medical History 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the scimitar Mr injection 0,75% to 2 sol. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Do not provoke bronchospasm.